VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation
Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur...
Saved in:
Published in | Advances in cancer research Vol. 138; pp. 41 - 69 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
2018
|
Subjects | |
Online Access | Get full text |
ISSN | 2162-5557 0065-230X 2162-5557 |
DOI | 10.1016/bs.acr.2018.02.002 |
Cover
Abstract | Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH
that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential (ΔΨ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ-Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC-tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC-tubulin interaction promotes cell death by a "double-hit model" characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress. |
---|---|
AbstractList | Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH
that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential (ΔΨ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ-Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC-tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC-tubulin interaction promotes cell death by a "double-hit model" characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress. Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH2 that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential (ΔΨ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ-Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC-tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC-tubulin interaction promotes cell death by a "double-hit model" characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress.Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH2 that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential (ΔΨ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ-Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC-tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC-tubulin interaction promotes cell death by a "double-hit model" characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress. Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH 2 that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential ( ΔΨ ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ -Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC–tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC–tubulin interaction promotes cell death by a “double-hit model” characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress. |
Author | Fang, Diana Maldonado, Eduardo N |
AuthorAffiliation | Medical University of South Carolina, Charleston, SC, United States Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States |
AuthorAffiliation_xml | – name: Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States – name: Medical University of South Carolina, Charleston, SC, United States |
Author_xml | – sequence: 1 givenname: Diana surname: Fang fullname: Fang, Diana organization: Medical University of South Carolina, Charleston, SC, United States – sequence: 2 givenname: Eduardo N surname: Maldonado fullname: Maldonado, Eduardo N email: maldona@musc.edu organization: Medical University of South Carolina, Charleston, SC, United States; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States. Electronic address: maldona@musc.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29551129$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkEtLxDAUhYOMOA_9Ay4kSzetSdokjQthrE8YUXRwW9I0nYl0mpqkgv_eoqOMq3vhnvsdzpmCUWtbDcAxRjFGmJ2VPpbKxQThLEYkRojsgQnBjESUUj7a2cdg6v3bIOAZzg7AmAhKMSZiAi5fr-Y5fNarvpHB2PYczuGDCVatbVs5Ixu4lG6lAwwWvgTbwVw3DXxytjG1dt8vh2C_lo3XR9s5A8ub62V-Fy0eb-_z-SLqCGMhSphgsiqllJyzOi15kqZlxVSNSsmR4rWuRKo5xbzOdKbKjHNBiUwUYSkRKJmBix9s15cbXSndBiebonNmI91nYaUp_l9asy5W9qNgJEkFZwPgdAtw9r3XPhQb49UQR7ba9r4YeqQpEkNng_Rk1-vP5Le35Avse3LU |
ContentType | Journal Article |
Copyright | 2018 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2018 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/bs.acr.2018.02.002 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2162-5557 |
EndPage | 69 |
ExternalDocumentID | PMC6234976 29551129 |
Genre | Journal Article Review Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA184456 – fundername: NIGMS NIH HHS grantid: P20 GM103542 |
GroupedDBID | --- --K -~X .GJ 0R~ 23M 34R 3O- 53G 5GY 5RE 85S 8N7 8NA 8NF AAXUO AAYSV ABGWT ABMAC ABQQC ABSWN ACGFS ACXMD AENEX AFFNX AFOST AFTJW AGAMA AHMUE AI. AJBBN AKRWK ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF C45 CGR CS3 CUY CVF ECM EIF F5P FDB FEDTE HVGLF HZ~ JDP L7B MVM NEJ NPM O9- OVD P2P SBF SDK SES SHL TEORI UDS VH1 VQP WH7 X7N ZGI ZXP 7X8 AALRI 5PM |
ID | FETCH-LOGICAL-p266t-3696adbaaa776f4b7344bd6cf0ba70c7fed94e7517f8e8cb877952a3c2642903 |
ISSN | 2162-5557 0065-230X |
IngestDate | Thu Aug 21 18:24:15 EDT 2025 Fri Jul 11 11:03:06 EDT 2025 Thu Apr 03 07:02:24 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Oxidative stress Mitochondria Tubulin Cancer metabolism Glycolysis Erastin Voltage-dependent anion channel Warburg effect |
Language | English |
License | 2018 Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p266t-3696adbaaa776f4b7344bd6cf0ba70c7fed94e7517f8e8cb877952a3c2642903 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
PMID | 29551129 |
PQID | 2015409162 |
PQPubID | 23479 |
PageCount | 29 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6234976 proquest_miscellaneous_2015409162 pubmed_primary_29551129 |
PublicationCentury | 2000 |
PublicationDate | 2018-00-00 20180101 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – year: 2018 text: 2018-00-00 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Advances in cancer research |
PublicationTitleAlternate | Adv Cancer Res |
PublicationYear | 2018 |
SSID | ssj0027818 |
Score | 2.5257735 |
SecondaryResourceType | review_article |
Snippet | Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype... |
SourceID | pubmedcentral proquest pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 41 |
SubjectTerms | Animals Antineoplastic Agents - pharmacology Cell Proliferation - drug effects Energy Metabolism Humans Mitochondria - drug effects Mitochondria - metabolism Mitochondria - pathology Neoplasms - drug therapy Neoplasms - metabolism Neoplasms - pathology Voltage-Dependent Anion Channels - metabolism |
Title | VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29551129 https://www.proquest.com/docview/2015409162 https://pubmed.ncbi.nlm.nih.gov/PMC6234976 |
Volume | 138 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BKiEuFdACKQ8tUm-VkePsw-YW2kYRVXooofQW7cstEthR6l749czsbuyEBgm4WJZtbaT5xpNvxzPfEHIIFEOnTBVJzoVNmLIsQfnbpBTWgBMpyw02Ck_PxeQL-3TFr7pxf767pNHvzc-tfSX_gypcA1yxS_YfkG0XhQtwDvjCERCG419hfHkyQgNdxxFcoct8Cu8oxLTK-nkcM1_pjQzzc1Mvjo59qg4n9ZRu2YGykqENBQG-RNbg2fIoigG1SeNxzC-fgFu1EX2qvltg9NanXU8tel0dv_HEhEKMfs6HnGwgYGvKg2R0Gx-D_EqMcEGm6l7gDTkAfQtegCqrgzwooWbrD4MVFj88FFnBPdHr_oTa0sDVrYdkJ5NywHtkZ3R28fWs20UDxYjdT1iod_8nUd85LrJt2_B79esanZg9IbtxH0BHAdSn5IGrnpFH01jpsEc-Ira0w_YDHdENZGlAljY1RWQpIks3kN0ns_Hp7HiSxHkXyQJoUpPgaEVltVJKSlEyLYeMaStMmWolUyNLZwvmJB_IMne50bmUBc_U0ACpzYp0-Jz0qrpyLwm1IpWqTEsHdJwpZ_LcWK6EtUzDfpIVffJuZZc5hBP8RqQqV9_dzjPk1MAhRdYnL4Kd5ougezJfWbVP5IYF2wdQqnzzTvXtxkuWA8lmQHwP_rjmK_IYIQzJrdek1yzv3Buge41-Gx3gFyt_Vj8 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=VDAC+Regulation%3A+A+Mitochondrial+Target+to+Stop+Cell+Proliferation&rft.jtitle=Advances+in+cancer+research&rft.au=Fang%2C+Diana&rft.au=Maldonado%2C+Eduardo+N&rft.date=2018&rft.eissn=2162-5557&rft.volume=138&rft.spage=41&rft_id=info:doi/10.1016%2Fbs.acr.2018.02.002&rft_id=info%3Apmid%2F29551129&rft.externalDocID=29551129 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2162-5557&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2162-5557&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2162-5557&client=summon |